Health Catalyst, Inc. current report, 10 June 2021

Health Catalyst, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K, dated June 10, 2021, reports the results of Health Catalyst, Inc.'s Annual Meeting of Stockholders. The meeting was held to vote on four proposals detailed in the definitive proxy statement filed on April 27, 2021.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Out of 44,475,560 shares entitled to vote, 38,626,363 shares were present or represented by proxy. The results for the four proposals were as follows:

  • Proposal 1 (Election of Directors): All three Class II director nominees (Daniel Burton, John A. Kane, and Julie Larson-Green) were elected to three-year terms.
  • Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
  • Proposal 3 (Executive Compensation): Stockholders approved the advisory, non-binding proposal to approve the compensation of named executive officers.
  • Proposal 4 (Frequency of Say-on-Pay): Stockholders voted to hold the advisory vote on executive compensation annually (1 Year).

Guidance, Outlook, and Risks

The filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It serves strictly as a disclosure of the voting outcomes.

Key Facts for Investor Verification

  • Verify the specific terms of the director elections and the tenure of the newly elected Class II directors.
  • Confirm the ratification of Ernst & Young LLP as the auditor for the 2021 fiscal year.
  • Note the significant number of votes withheld or cast against in the executive compensation proposal (Proposal 3), where approximately 38% of votes cast were against the proposal.
  • Review the definitive proxy statement filed on April 27, 2021, for detailed background on the proposals and executive compensation specifics.